Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing

Simple item page
dc.contributor.authorJan de Beur, Suzanne M.
dc.contributor.authorMiller, Paul D.
dc.contributor.authorWeber, Thomas J.
dc.contributor.authorPeacock, Munro
dc.contributor.authorInsogna, Karl
dc.contributor.authorKumar, Rajiv
dc.contributor.authorRauch, Frank
dc.contributor.authorLuca, Diana
dc.contributor.authorCimms, Tricia
dc.contributor.authorScott Roberts, Mary
dc.contributor.authorSan Martin, Javier
dc.contributor.authorCarpenter, Thomas O.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-08-02T14:07:29Z
dc.date.available2023-08-02T14:07:29Z
dc.date.issued2021
dc.eprint.versionFinal published version
dc.identifier.citationJan de Beur SM, Miller PD, Weber TJ, et al. Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing. J Bone Miner Res. 2021;36(12):2455-2456. doi:10.1002/jbmr.4317
dc.identifier.urihttps://hdl.handle.net/1805/34682
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1002/jbmr.4317
dc.relation.journalJournal of Bone and Mineral Research
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectOsteomalacia
dc.subjectParaneoplastic syndromes
dc.subjectHumanized monoclonal antibodies
dc.titleReply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JBMR-36-2455.pdf
Size:
88.48 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works